HOME >> MEDICINE >> NEWS
Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study

HOUSTON - The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.

The risk was first discovered and reported last September by the study's safety monitoring board and led to the shutdown of the colon cancer chemoprevention trial and subsequent withdrawal of the drug from the U.S. market.

The trial, known as APPROVe (Adenomatous Polyp Prevention on Vioxx), was the longest test yet of Vioxx as a chemoprevention agent, and was designed to determine whether the drug could prevent the re-growth of precancerous colon polyps in people who had already had polyps removed. The prospective chemoprevention study randomized 2,586 participants from 108 centers in 29 countries to receive either 25 mgs. of Vioxx daily or a placebo drug for three years, 2001-2004. The trial was stopped September 30, 2004 - approximately two months before its planned completion.

According to Robert S. Bresalier, M.D., of The University of Texas M. D. Anderson Cancer Center and lead author of The New England Journal of Medicine study, 46 of the 1287 patients randomized to take Vioxx daily had confirmed cardiovascular events over a three year period - mostly heart attacks or strokes. In the 1,299 patients given a placebo drug, there were 26 events. Each group, however, had the same number of deaths and not all were related to heart attacks or strokes.

"The overall number of cardiovascular events is small, but, nevertheless, the difference between the groups is significant," says Bresalier, who is professor and chair of the Department of Gastrointestinal Medicine and Nutrition at M. D. Anderson and a member of the study's steering committee.

This study
'"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
15-Feb-2005


Page: 1 2 3

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers offer emergency workers a lifeline
8. Researchers discover genetic variant that may explain why women develop M.S. more than men
9. Researchers map the sexual network of an entire high school
10. Researchers hope monkeys can provide new insights into depression
11. Researchers identify the link between heart failure and weight loss

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2019)... (PRWEB) , ... May 21, 2019 , ... ... for Interoperability[1], mandated by the 2015 21st Century Cure Act[2], calls for the ... for all electronic health records. The American Medical Informatics Association; however, recommends that ...
(Date:5/21/2019)... ... ... Coral Detection Systems recently went to market with the first and only drowning ... software and an underwater video camera to analyze, detect, and track all people in ... entrance to the water, and more importantly, upon detection of risk of drowning. ...
(Date:5/21/2019)... GAITHERSBURG, Md. (PRWEB) , ... May 21, 2019 , ... ... with a safe, proven and effective solution: vaccination. , Between January 1, 2019 and ... of measles across 23 states. Worryingly, this number includes a 60 case jump between ...
(Date:5/21/2019)... ... 2019 , ... CEO Steven C. Bilt of Smile Brands ... of Corporate Growth Awards last week. ACG supports middle-market dealmakers and business leaders ... support organization with over 400 affiliated practices across 17 states, has a deeply ...
(Date:5/21/2019)... (PRWEB) , ... May 21, 2019 , ... ... impact of new drugs on cognition, as any drug that crosses the blood-brain ... medications and the aging process itself can all compromise the integrity of the ...
Breaking Medicine News(10 mins):
(Date:5/21/2019)... ... May 21, 2019 , ... ... advocacy effort known as the Donor Champion Program. Created through a 3-way collaboration ... Donors Network, the Donor Champion Program was developed with transplant patients and their ...
(Date:5/21/2019)... ... May 21, 2019 , ... The evolution of the cannabis ... new product categories becoming available in the market. Large and small companies alike ... the consumer. However, there are many challenges in formulating any consumable product and ...
(Date:5/21/2019)... LOS ANGELES (PRWEB) , ... May 21, 2019 ... ... revenue cycle management (RCM) solutions to Healthcare Providers and Payers, announced today that ... Intelligence and Artificial Intelligence Conclave. , The Conference brings together hundreds of leading ...
Breaking Medicine Technology:
Cached News: